Related Experiment Video
Updated: May 4, 2026
08:34
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
17.2K
Leptin and obesity in humans.
1Division of Endocrinology and Metabolism, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Eating and Weight Disorders : EWD
|June 1, 1997
Summary
Leptin, a hormone signaling adipose tissue, regulates body fat in animals. Obese humans may be resistant to leptin, suggesting a role in human obesity.
Area of Science:
- Endocrinology
- Neuroscience
- Obesity Research
Background:
- The lipostasis theory proposed a peripheral signal informing the central nervous system about body fat.
- Leptin has been identified as this crucial peripheral signal.
- Rodent studies demonstrate leptin's role in regulating body composition and fat mass.
Purpose of the Study:
- To investigate the role of leptin in regulating body composition.
- To explore the potential connection between leptin signaling and human obesity.
- To determine if defects in the leptin system contribute to obesity in humans.
Main Methods:
- Review of existing animal studies on leptin and obesity.
- Analysis of genetic defects in the ob gene and leptin receptor in rodents.
- Observation of leptin's effects and potential resistance in obese human populations.
Main Results:
- Leptin's ability to regulate body composition and fat is confirmed in animal models.
- Genetic defects in leptin or its receptor cause obesity in rodents.
- No similar genetic defects found in humans; obese humans exhibit leptin resistance.
Conclusions:
- Leptin is a key peripheral signal for the central nervous system regarding adipose tissue.
- Obesity in humans may be linked to resistance to endogenous leptin.
- Further research, including leptin administration in humans, is needed to fully understand its role in human obesity.
More Related Videos
08:06Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
8.7K
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
662
Related Concept Videos
01:30Regulation of Food Intake
2.8K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.8K
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17